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doi:10.1016/j.jfma.2011.06.018Background/Purpose: Rapid diagnosis of influenza was important in the global pandemic influ-
enza A/H1N1 outbreak. The QuickVue Influenza AþB test is one of the most common tests for
rapid diagnosis of influenza. We evaluated the sensitivity and specificity of the test in children.
Methods: We collected data from 970 patients with influenza-like illness who received rapid
influenza antigen tests using the QuickVue Influenza AþB test as well as viral isolation. We
compared the results with that of viral isolation and reverse-transcriptase polymerase chain
reaction (RT-PCR) assays.
Results: Based on viral culture, the QuickVue Influenza AþB test had an overall sensitivity of
0.82 (419/513) and specificity of 0.99 (70/71), with a positive predictive value (PPV) of 0.74
(419/563) and a negative predictive value (NPV) of 0.77 (313/407). The sensitivity of QuickVue
was significantly higher in specimens with high viral loads. If the viral loads were less than 106,
the sensitivity of QuickVue was 0.62, while the sensitivity of QuickVue was 0.88 if the viral
loads were higher than 106 (p< 0.001). Logistic regression analysis showed that higher viral
loads correlated with positive QuickVue results (p< 0.001). On the first day of fever, the sensi-
tivity of QuickVue was only 0.67; on the second day, the sensitivity was 0.86; on the third day,
the sensitivity was 0.98, and on the fourth day, the sensitivity was 0.90. The sensitivity is
significantly higher on days 23 in comparison with the first day of fever (p< 0.05). We calcu-
lated the correlation of viral load and fever days, and the result showed higher mean viral load
on the second and third days of fever. Age did not affect the sensitivity.
Conclusion: In children, the sensitivity of QuickVue Influenza AþB test was 0.82. In addition, the
sensitivity was significantly elevated in the higher viral load group and on the third day of fever.
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tion of Influenza Virus type A and type B antigens directlyPandemic influenzaA (H1N1) rapidly swept through thewhole
world soon after its inception in late March 2009.1 With a high
disease burden and many patients consulting health care
facilities, rapiddiagnosis of influenza infectionwas important
for both timely antiviral therapy and infection control. Viral
cultureusedtobethegold standard fordiagnosis of influenza.
Reverse-transcriptase polymerase chain reaction (RT-PCR) is
a recommend diagnostic method with high sensitivity and
specificity. However, the turn-around time of viral culture is
several days and RT-PCR is only available in some sophisti-
cated laboratories. Rapid influenza antigen tests can provide
a diagnosis within 30minutes and require only simple training
of personnel. Previous studies have reported that rapid
antigen tests have high specificity and moderate
sensitivity.1e7 However, most of the studies were based on
experience with seasonal influenza, and the use of rapid
antigentests inpandemicA/H1N1 influenzawere lacking.The
QuickVue Influenza AþB test is one of the most commonly
used rapid tests for influenza. Our hospital adopted this
specific kit for large-scale screening in the outpatient clinic
and in Emergency services. Hence, we had the chance to
prospectively evaluate the sensitivity and specificity of the
test in children together with viral culture and RT-PCR.
Methods
Patient and specimen collection
FromAugust 18, 2009 toNovember 24, 2009,weprospectively
identified 970 patients with influenza-like illness from pedi-
atric outpatient clinics and wards in Taiwan. Patients ranged
inage from10days to50years old.Anasopharyngeal swaband
two separate throat swabs were collected. The specimens of
throat swabs were sent to the laboratory for viral culture and
real-time RT-PCR. The nasopharyngeal swab was tested
within 30 minutes using the rapid influenza antigen test.
Viral culture
All of the specimens were tested by viral culture which was
used as the gold standard for H1N1 influenza diagnosis in this
study.Virus isolationwasperformedwith standardprotocol in
the virology laboratory of the tertiary medical center. Mad-
inDarby Canine Kidney Epithelial (MDCK) cells were
employed as cell cultures. The samples were stained with
specific fluorescein-conjugated monoclonal antibodies
(Influenza virus A and B kit, Oxoid, catalogue No. 610511,
Basingstoke, Hampshire,UnitedKingdom) in order to perform
a direct and indirect immunofluorescence assay. The samples
were also added to anti-influenza A, H1 Antigen (Light Diag-
nostics Catalogue No MAB8252, Billerica, USA) and anti-
influenza A, H3 Antigen (Light Diagnostics Catalogue No
MAB8254,Billerica,USA) todefine influenzaAH1N1andH3N2.
Rapid antigen test for influenza
Antigen-based rapid tests for influenza were performed
using QuickVue Influenza AþB test (Quidel Corporation, SanDiego, CA 92121 USA) and an immunoassay for the detec-
from nasopharyngeal swab specimens, in accordance with
manufacturer instructions. For nasopharyngeal swab
collection, the Dacron swab was inserted through the
anterior naris to the posterior nasopharynx until resistance
was met. It was left in place for a few seconds and removed
slowly while being rotated. The swab was then placed in
a tube containing 0.5 mL normal saline (0.9% w/v NaCl).
The test strip with specific mouse monoclonal antibodies
for influenza A and B viruses was used to react with viral
antigens from swab specimens. A positive patient sample
produced a red line on the test strip.8
Real-time reverse transcription-polymerase chain
reaction
Influenza A virus RNA was isolated from throat swabs using
the MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche
Inc., Mannheim, Germany). Real-time RT-PCR was per-
formed using a LightCycler RNA Master System (Roche Inc.,
Mannheim, Germany) with 2.5 ml RNA in a 10 ml reaction
mixture. The primers, forward 50-CATTTGAAAGGTTTGAGA
TATTCCC-30 and reverse 50-GGACATGGAGCCGTTACACC-30,
and the probe, FAM (fluorescein amidite)-ACAAGTT-
CATGGCCCAATCATGACTCG-BHQ1 (Black Hole Quencher 1),
were designed for detection of influenza A hemaglutinin
(HA1) (positions 379434). The RT-PCR product was cloned
into a TA cloning vector (yT&A vector, Yeastern Biotech,
Taipei, Taiwan) to generate a DNA construct. The in vitro
transcribed RNA was purified and quantified to determine
the copy number and was subsequently used as the positive
template for real-time RT-PCR. The sensitivity of the real-
time RT-PCR was 40 copies of in vitro transcribed RNA.
Statistical analysis
We calculated the sensitivity, specificity, and positive and
negative predictive value (PPV and NPV, respectively) of
the rapid antigen test compared with viral culture as the
gold standard. Sensitivity measures the proportion of
positive rapid antigen test in patients with positive influ-
enza culture. Specificity measures the proportion of nega-
tive rapid antigen test in patients with positive viral culture
except influenza virus and herpes group virus. PPV was
calculated as the proportion of patients with positive
influenza culture in the positive rapid antigen test group.
NPV was calculated as the proportion of patients with
negative influenza culture in the negative rapid antigen
test group. Data analysis was performed using SPSS, version
15.0 (SPSS Inc., Chicago, IL, USA). A p value < 0.05 was
considered statistically significant.
Results
Demography
From August 18, 2009 to November 24, 2009, 970 patients
were enrolled in our study. All of the patients were
assessed in pediatric outpatient clinics or wards. The
Table 2 Sensitivity of the QuickVue Influenza AþB Test
depends on the duration of symptom onset and testing.
Testing date
(days after
symptom onset)
No. of
positive
virus culture
No. of
positive
rapid test
Sensitivity p*
No fever 13 5 0.39 < 0.001
D1 118 79 0.67
D2 211 182 0.86
D3 82 80 0.98
D4 30 27 0.90
 D5 14 8 0.57
*p value was measured using the chi-square test.
D1Z the first day of fever; D2Z the second day of fever; D3Z
the third day of fever; D4Z the fourth day of fever;  D5Z the
fifth day of fever or later.
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age from 10 days to 50 years. The number of children aged
< 18 years old were 921 (94.9%) and only 49 were adults,
most of whom were household members of the children
patients. The median age was 8.41 years. Among the 970
patients, influenza A was identified by viral culture in 513
patients, including 502 cases of novel H1N1 influenza, 10
cases of H3N2 and one case of seasonal H1N1 influenza. In
the groups of influenza infection, there were 419 positive
rapid antigen tests. Of the 71 patients with other viral
infections such as respiratory syncytial virus or enterovirus,
except herpes group virus, 70 had a negative rapid antigen
test. Among all of the patients, 563 had a positive rapid
antigen test and 419 of those patients were confirmed to
have influenza infection by viral culture. Of the other 407
patients with a negative rapid antigen test, 313 had
a negative influenza viral culture.
Sensitivity and specificity
Based on viral culture, the QuickVue Influenza AþB test had
an overall sensitivity of 0.82 (419/513) and a specificity of
0.99 (70/71), with a PPV of 0.74 (419/563) and an NPV of
0.77 (313/407). The result is shown in Table 1. When the
age of the children was compared with sensitivity, there
was no significant difference (Table 1).
Clinical manifestations and sensitivity
We reviewed the medical records of 513 patients with
influenza A infection. Among them, 500 patients had fever
and 13 patients did not. In the 500 febrile patients, 455
patients recorded their highest fever on the day of fever
onset. We correlated sensitivity and sampling days, and the
results are shown in Table 2. On the first day of fever, the
sensitivity of QuickVue was only 0.67; on the second day of
fever, the sensitivity was 0.86; on the third day of fever,
the sensitivity was 0.98, and on the fourth day of fever, the
sensitivity was 0.90. The sensitivity is significantly higher on
days 24 in comparison with that on the first day of fever
(p< 0.001).Table 1 Sensitivity of QuickVue Influenza AþB test
compared to viral culture as reference standard, stratified
by age and gender.
Characteristic No. of
positive
virus culture
No. of
positive
rapid test
Sensitivity p*
Age, y 0.43
06 141 112 0.79
712 258 213 0.83
1317 93 79 0.85
> 18 21 15 0.71
Gender 0.16
Male 245 194 0.79
Female 268 225 0.84
*p value was measured using the chi-square test.Viral loads and sensitivity
Viral culture and RT-PCR were performed for all of the
patients. Influenza A was identified by viral culture in 513
patients and there were 502 cases of novel H1N1 influenza,
10 cases of H3N2, and one case of seasonal H1N1 influenza.
Among the 502 cases of positive novel H1N1 influenza by
viral culture, we compared viral loads with the sensitivity
of the QuickVue Influenza AþB test. The sensitivity of
QuickVue was significantly higher in specimens with high
viral loads (Table 3). If the viral loads were less than
1,000,000 copies/mL, the sensitivity of QuickVue was 0.62
while the sensitivity of QuickVue was 0.89 if the viral loads
were higher than 1,000,000 copies/mL (p< 0.001).
Discussion
During the global pandemic influenza A/H1N1 outbreak in
2009, laboratory diagnosis was very important because of
similar clinical symptoms for influenza and other respiratory
viral infections. In our study, the overall sensitivity of the
QuickVue Influenza AþB test was 0.82 and the specificity was
0.99. Vasoo et al5 analyzed three rapid influenza antigenTable 3 Sensitivity of QuickVue Influenza AþB test
compared to viral culture as reference standard, correlated
with viral load by real time RT-PCR.
Viral load
by RT-PCRa
Number of
positive virus
cultures
Number with
positive results
Sensitivity p*
< 104 35 21 0.60 < 0.001
104105 27 14 0.52
105106 88 60 0.68
> 106 352 313 0.89
*p value was measured using the chi-square test.
If the viral loads were higher than 1,000,000 copies/mL, the
sensitivity of the QuickVue test was higher than if the viral loads
were less than 1,000,000 copies/mL (p< 0.001).
RT-PCR Z reverse-transcriptase polymerase chain reaction.
a Data were expressed as copies/mL.
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Directigen EZ Flu AþB test (BectonDickinson, Franklin Lakes,
NJ USA), BinaxNOW Influenza A&B (Inverness Medical, Gal-
way Ireland), and QuickVue Influenza AþB Test (Quidel,
QuickVue,McKellar Court, SanDiego,USA) and the sensitivity
of QuickVue Influenza AþB Test was higher than the others.
Cheng et al6 provided that the sensitivity of QuickVue Influ-
enza AþB test in all age group was 0.68 and the study pop-
ulation in their study was mostly adults. Our patients in this
study were almost all children (median age 8.41 years) and
the sensitivity was obviously higher than in previous studies
where the median age was> 18 years.1e7 We calculated the
sensitivity of the pediatric group at different ages and the
results showed no differences.
With pandemic H1N1 influenza A infection, the most
common symptom was fever.9 We compared the sensitivity
of the rapid influenza antigen test with fever onset days.
The sensitivity was highest (0.98) on day 3 of fever and the
sensitivity was relatively lower on day 1 and in cases of
fever lasting more than 5 days. Watanabe et al10 also re-
ported that the rapid immunoassay test for influenza was
less sensitive for diagnosis in the early phase of the disease
in pediatric group. The Centers of Disease Control and
Prevention (CDC) suggest that antiviral treatment is most
effective when started in the first 48 hours of illness.15
Thereafter, the sensitivity of the rapid influenza antigen
test in our study was relative low during the first day of
fever. Influenza should be diagnosed on the basis of clinical
symptoms within 24 hours after fever onset so that anti-
influenza drugs can be administered.
As previously discussed, our study showed higher sensi-
tivity for the rapid influenza antigen test in pediatric
groups than other studies have shown in adult groups. We
surveyed the cause of the different results of sensitivity in
adults and children. Previous studies reported that children
have higher viral loads than adults. 11,12 Calvin et al6
provided that viral loads were on average higher for chil-
dren aged < 16 years. Compared with the rapid influenza
antigen test and viral load in the previous study, the overall
mean of viral load of 105.6 TCID50/mL (50% tissue culture
infective dose) with positive rapid antigen test results were
significantly higher than the mean viral load of 103.7
TCID50/mL of negative rapid antigen test results.
13,14 In our
study, the sensitivity was significantly increased if viral
load was higher than 106 copies/mL. The median viral load
in our study was 4.28 106 copies/mL. This may clarify why
higher sensitivity was observed in the pediatric group.
There are a few limitations in our study. First, viral
culture was the gold standard in this study. We estimated
the specificity by detecting other virus pathogens in the
culture as a negative group. This method increased the
specificity due to the sensitivity of viral culture, which
would decrease due to the loss of virus viability during
transportation or freezing, particularly for specimens with
lower viral titers. However, NPV could not be calculated by
this method and NPV would be overestimated. Second, we
calculated the sensitivity and days since the onset of fever
and the results showed a significant correlation. We
collected the patients in different outpatient clinics and
the record of fever onset may not be reliable. Third, the
populations in our study were mostly children. We would
need to test a larger adult group in order to moreaccurately compare results with the pediatric group.
Fourth, we should investigate the correlation of sensitivity
and other symptoms and determine how to increase the
sensitivity of the rapid influenza antigen test.
Conclusion
In children, the sensitivity of the QuickVue Influenza AþB
test was higher than in adults. In addition, the sensitivity
was increased significantly in patients with higher viral
loads and on day 3 of the onset of fever.References
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